Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Aspira Women's Health Inc./ 10-Q

Quarterly Report · 10-Q

Aspira Women's Health Inc.

AWHLOTCEQUITYCurrent

Quarterly Report

Filed May 15, 2023Accepted May 15, 2023, 5:15 PM EDTCIK 926617Accession 0000926617-23-000046
View company →Permanent SEC source ↗
Share

Company context

We are dedicated to the discovery, development, and commercialization of noninvasive, AI-powered tests to aid in the diagnosis of gynecologic diseases, starting with ovarian cancer.

Current securities

AWHLOTC · EQUITY · Current

Recent company filings

  1. 10-Q filingAug 14, 2026
  2. Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet ArrangementJul 15, 2026
  3. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsJul 7, 2026
  4. D filingJun 22, 2026
  5. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsJun 22, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗